BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37001337)

  • 1. Screening for Kidney Disease in Low- and Middle-Income Countries.
    Kalyesubula R; Conroy AL; Calice-Silva V; Kumar V; Onu U; Batte A; Kaze FF; Fabian J; Ulasi I
    Semin Nephrol; 2022 Sep; 42(5):151315. PubMed ID: 37001337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
    George C; Echouffo-Tcheugui JB; Jaar BG; Okpechi IG; Kengne AP
    BMC Med; 2022 Aug; 20(1):247. PubMed ID: 35915501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Dickinson JA
    J Am Soc Nephrol; 2020 Sep; 31(9):1931-1940. PubMed ID: 32839279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global perspective of kidney diseases: Challenges and changes.
    Nangaku M
    Nephrology (Carlton); 2023 Aug; 28 Suppl 1():5-7. PubMed ID: 37534846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention programs for chronic kidney disease in low-income countries.
    Perico N; Remuzzi G
    Intern Emerg Med; 2016 Apr; 11(3):385-9. PubMed ID: 26983956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease in low- and middle-income countries.
    Stanifer JW; Muiru A; Jafar TH; Patel UD
    Nephrol Dial Transplant; 2016 Jun; 31(6):868-74. PubMed ID: 27217391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic kidney disease stages 3-5 in low- and middle-income countries in Asia: A systematic review and meta-analysis.
    Suriyong P; Ruengorn C; Shayakul C; Anantachoti P; Kanjanarat P
    PLoS One; 2022; 17(2):e0264393. PubMed ID: 35213610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
    Ke C; Liang J; Liu M; Liu S; Wang C
    BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urbanization and kidney function decline in low and middle income countries.
    Jagannathan R; Patzer RE
    BMC Nephrol; 2017 Aug; 18(1):276. PubMed ID: 28851306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, coverage, and scope of health information systems for kidney care across world countries and regions.
    See EJ; Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Davison S; Ghnaimat M; Harden P; Htay H; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx V; Neuen B; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; Syed S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Kazancioglu RT; Wang AY; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey F; Perkovic V; Jindal KK; Okpechi IG; Tonelli M; Feehally J; Harris DC; Johnson DW
    Nephrol Dial Transplant; 2021 Dec; 37(1):159-167. PubMed ID: 33351951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Kidney Disease.
    Webster AC; Nagler EV; Morton RL; Masson P
    Lancet; 2017 Mar; 389(10075):1238-1252. PubMed ID: 27887750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities.
    Hustrini NM
    Acta Med Indones; 2023 Jan; 55(1):1-3. PubMed ID: 36999266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.
    Okpechi IG; Caskey FJ; Gaipov A; Tannor EK; Hamonic LN; Ashuntantang G; Donner JA; Figueiredo A; Inagi R; Madero M; Malik C; Moorthy M; Pecoits-Filho R; Tesar V; Levin A; Jha V
    BMJ Open; 2021 Dec; 11(12):e053857. PubMed ID: 34916325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of screening for Chronic Kidney Disease.
    Djukanović Lj
    Prilozi; 2010; 31(1):249-59. PubMed ID: 20693945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and early detection of chronic kidney disease at primary healthcare.
    Nagib SN; Abdelwahab S; Amin GEE; Allam MF
    Clin Exp Hypertens; 2021 Jul; 43(5):416-418. PubMed ID: 33726610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Low Socioeconomic Status on Progression of Chronic Kidney Disease in Low- and Lower Middle-Income Countries.
    Tannor EK; Chika OU; Okpechi IG
    Semin Nephrol; 2022 Sep; 42(5):151338. PubMed ID: 36966563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.
    Mills KT; Xu Y; Zhang W; Bundy JD; Chen CS; Kelly TN; Chen J; He J
    Kidney Int; 2015 Nov; 88(5):950-7. PubMed ID: 26221752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of early identification of chronic kidney disease.
    Whaley-Connell A; Nistala R; Chaudhary K
    Mo Med; 2011; 108(1):25-8. PubMed ID: 21462606
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.